Session: CMES204-The Great Insulin Debate: A Critical Review of Advances in Insulin Therapy
Supported by an educational grant from Novo Nordisk Inc.
Yerba Buena Salon 7 (San Francisco Marriott Marquis)
Summarize the benefits and limitations of current insulin analogues Describe the clinical important differences between current and emerging insulins to the extent data is available in: (1) Glycemic efficacy, hypoglycemia, and pharmacodynamics; (2) Quality-of-life, including dosing frequency, adherence and impact on weight; (3) Special populations including pediatrics, pregnancy, older adults, and renal insufficiency Describe recent advances in insulin therapy and their implications for clinical practice
See more of: CMES Ancillary Events